×
A Pharmacokinetic and Clinical Evaluation of Switching Patients With Bipolar I Disorder From Delayed-Release to Extended-Release Divalproex PDF
$ 40.00
A Pharmacokinetic and Clinical Evaluation of Switching Patients With Bipolar I Disorder From Delayed-Release to Extended-Release Divalproex PDF quantity
$ 40.00
×
Prevalence, Correlates, and Comorbidity of Nonmedical Prescription Drug Use and Drug Use Disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions. PDF
$ 40.00
Prevalence, Correlates, and Comorbidity of Nonmedical Prescription Drug Use and Drug Use Disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions. PDF quantity
$ 40.00
×
Health-Related Quality of Life Across the Anxiety Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) PDF
$ 40.00
Health-Related Quality of Life Across the Anxiety Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) PDF quantity
$ 40.00
×
The Efficacy and Safety of the Melatonin Agonist beta-Methyl-6-Chloromelatonin in Primary Insomnia: A Randomized, Placebo-Controlled, Crossover Clinical Trial PDF
$ 40.00
The Efficacy and Safety of the Melatonin Agonist beta-Methyl-6-Chloromelatonin in Primary Insomnia: A Randomized, Placebo-Controlled, Crossover Clinical Trial PDF quantity
$ 40.00
×
Amisulpride: A Useful Second-Generation Antipsychotic Omitted From the US Residency Training Curriculum PDF
$ 40.00
Amisulpride: A Useful Second-Generation Antipsychotic Omitted From the US Residency Training Curriculum PDF quantity
$ 40.00
×
Efficacy and Safety of Loxapine for Inhalation in the Treatment of Agitation in Patients With Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial PDF
$ 40.00
Efficacy and Safety of Loxapine for Inhalation in the Treatment of Agitation in Patients With Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial PDF quantity
$ 40.00
×
Efficacy of Venlafaxine Extended Release in Patients With Major Depressive Disorder and Comorbid Generalized Anxiety Disorder PDF
$ 40.00
Efficacy of Venlafaxine Extended Release in Patients With Major Depressive Disorder and Comorbid Generalized Anxiety Disorder PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart